Standalone and Consolidated Unaudited Financial Results for the Quarter and nine months ended 31st December, 2025.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.8 pts less than Nifty Microcap 250 and 5.0 pts less than its Commodity Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Polychem Ltd reported its unaudited results for Q3 FY26 and nine months ended December 2025. On a standalone basis, Q3 net sales fell to Rs 514.36 lakh (from Rs 612.35 lakh in Q3 FY25, a ~16% YoY decline), but net profit rose to Rs 81.93 lakh (from Rs 63.70 lakh, up ~29% YoY), aided by lower input costs and a fair-value gain on investments of Rs 36.81 lakh. For 9M FY26, standalone net sales grew ~10.5% to Rs 1,861.07 lakh and net profit rose ~12.3% to Rs 312.71 lakh (EPS Rs 77.39). On a consolidated basis, the picture is dramatically different: Q3 net profit jumped to Rs 2,546.70 lakh and 9M net profit to Rs 3,123.41 lakh (from Rs 265.81 lakh), driven primarily by a large one-time gain on disposal of land/development rights and fair-value gains on investments at the subsidiary level (Gujarat Poly Electronics). The statutory auditor (Nayan Parikh & Co.) issued an unqualified review report on both sets of results. Separately, the Board approved the re-appointment of Mr. Parthiv T. Kilachand as Managing Director for three years from 1 April 2026, subject to shareholder approval via postal ballot.
Shareholders should note that the headline surge in consolidated profit is largely due to exceptional, non-recurring gains from the transfer of land/development rights and fair-value remeasurement of investments, and is therefore not indicative of underlying operating performance. Standalone results, which better reflect core business trends, show revenue contracting in Q3 despite a margin-led profit rise — investors should focus on operating revenue trends rather than the inflated consolidated PAT.